Brendan P. Eckelman - 06 Dec 2022 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Signature
/s/ Kelly D. Deck, attorney-in-fact
Issuer symbol
INBX
Transactions as of
06 Dec 2022
Transactions value $
-$1,088,683
Form type
4
Date filed
07 Dec 2022, 15:30
Previous filing
02 Nov 2022
Next filing
04 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INBX Common Stock Sale -$562K -20.9K -0.95% $26.83 2.17M 06 Dec 2022 By the Eckelman Living Trust dated February 5, 2014 F1, F2, F3
transaction INBX Common Stock Sale -$487K -17.7K -0.81% $27.57 2.16M 06 Dec 2022 By the Eckelman Living Trust dated February 5, 2014 F1, F3, F4
transaction INBX Common Stock Sale -$39.6K -1.39K -0.06% $28.46 2.16M 06 Dec 2022 By the Eckelman Living Trust dated February 5, 2014 F1, F3, F5
holding INBX Common Stock 160K 06 Dec 2022 By trust F6
holding INBX Common Stock 160K 06 Dec 2022 By trust F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Eckelman Living Trust dated February 5, 2014.
F2 The shares were sold in multiple transactions at prices ranging from $26.24 to $27.22, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 These securities are directly owned by the Eckelman Living Trust dated February 5, 2014. Brendan P. Eckelman is the trustee of the Eckelman Living Trust dated February 5, 2014 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Eckelman Living Trust dated February 5, 2014.
F4 The shares were sold in multiple transactions at prices ranging from $27.24 to $28.23, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 The shares were sold in multiple transactions at prices ranging from $28.25 to $29.17, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F6 These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor son. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.
F7 These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor daughter. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust.